Experimental weight-loss drug found to help ease sleep disorders

Eli Lilly’s experimental weight-loss drug retatrutide reduced sleep apnea symptoms by over 50% in 68% of trial participants.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.